Glomerular diseases: membranous nephropathy-a modern view, Clin J Am Soc Nephrol, vol.9, p.23813556, 2014. ,
M-type phospholipase A2 receptor as target antigen in primary membranous nephropathy, N Engl J Med, vol.361, pp.11-21, 2009. ,
Prognosis of untreated patients with primary membranous nephropathy, N Engl J Med, vol.329, pp.85-89, 1993. ,
Spontaneous remission of nephrotic syndrome in primary membranous nephropathy, J Am Soc Nephrol, vol.21, pp.697-704, 2010. ,
Primary membranous nephropathy: the natural history of untreated patients, Kidney Int, vol.33, p.3367560, 1988. ,
A randomized trial of methylprednisolone and chlorambucil in primary membranous nephropathy, N Engl J Med, vol.320, pp.8-13, 1989. ,
A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by primary membranous nephropathy, J Am SocNephrol, vol.18, pp.1899-1904, 2007. ,
A controlled trial of cyclosporine in patients with progressive membranous nephropathy, Canadian Glomerulonephritis Study Group. Kidney Int, vol.47, p.7783410, 1995. ,
Cancer risk after cyclophosphamide treatment in primary membranous nephropathy, Clin J Am Soc Nephrol, vol.9, pp.1066-1073, 2014. ,
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient, Kidney Int, vol.82, p.22895519, 2012. ,
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy, N Engl J Med, vol.364, pp.689-690, 2011. ,
Antiphospholipase A2 receptor antibody titer and subclass in primary membranous nephropathy, J Am Soc Nephrol, vol.23, p.22956816, 2012. ,
Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy, J Am Soc Nephrol, vol.25, p.24610926, 2014. ,
PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system, PLoS ONE, vol.9, p.25313791, 2014. ,
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with primary membranous nephropathy, Kidney Int, vol.83, pp.940-948, 2013. ,
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy, Clin J Am Soc Nephrol, vol.9, pp.1883-1890, 2014. ,
Anti-phospholipase A? receptor antibodies correlate with clinical status in primary membranous nephropathy, Clin J Am Soc Nephrol, vol.6, p.21474589, 2011. ,
Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy, J Am SocNephrol, vol.22, pp.1543-1550, 2011. ,
Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy, J Am Soc Nephrol, 2016. ,
Thrombospondin type-1 domain-containing 7A in primary membranous nephropathy, N Engl J Med, vol.371, pp.2277-2287, 2014. ,
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy, J Clin Invest, vol.126, pp.2519-2532, 2016. ,
Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy, Nephrol Dial Transplant, vol.30, 2015. ,
Renal phospholipase A2 receptor in hepatitis B virusassociated membranous nephropathy, Am J Nephrol, vol.41, pp.345-353, 2015. ,
Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy, PLoS One, vol.11, 2016. ,
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy, Nephrology Dial Transplant, vol.28, pp.1839-1844, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00919114
Association of anti-PLAR antibodies with outcomes after immunosuppressive therapy in primary membranous nephropathy, Clin J Am Soc Nephrol, vol.9, pp.1386-1392, 2014. ,
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy, J Am Soc Nephrol, vol.26, pp.2545-2558, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02193793
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up, J Am Soc Nephrol, vol.27, issue.2016 ,
URL : https://hal.archives-ouvertes.fr/hal-01490466